(Q71001102)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Dosing implications of rapid elimination of trimethoprim-sulfamethoxazole in patients with cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

6

J L Blumer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

4

C M Myers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

author name string

M D Reed

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

R C Stern

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

J S Bertino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

T S Yamashita

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 February 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

303-307

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

Fixed combination drug therapy

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Treatment of meningitis and septicemia in infancy with a sulphamethoxazole/trimethorpim combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Intravenous trimethoprim-sulfamethoxazole in the treatment of serious infections in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Pharmacokinetic Profile of Trimethoprim-Sulfamethoxazole in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Pharmacokinetics of Sulfamethoxazole + Trimethoprim in Man and Their Distribution in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Pharmacokinetics of Methicillin in Patients with Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

A 5 YEAR CLINICAL EVALUATION OF A THERAPEUTIC PROGRAM FOR PATIENTS WITH CYSTIC FIBROSIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Dose-dependent changes in sulfamethazine kinetics in rapid and slow isoniazid acetylators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Mechanisms of nonlinear disposition kinetics of sulfamethazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

Trimethoprim-Sulfamethoxazole: In Vitro Microbiological Aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Spectrofluorimetric Method for the Determination of Trimethoprim in Body Fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981019-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(84)81019-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6607329%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference